Agios Pharmaceuticals, Inc.(AGIO)

Biotechnology · Cambridge, MA

$31.88+0.63 (+2.02%)

Delayed quote: Oct 6, 2026, 11:35 AM EDT

EBITDA Yield: N/A

Basis: Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The EBITDA yield is N/A as of 2026-10-06T15:35:25.789Z.

Stored calculation inputs

Calculation as of: 2026-10-06T15:35:25.789Z.

Quote observation: 2026-10-06T15:35:09.000Z. Amounts in USD. The price header may show a later quote.

TTM operating EBITDA · period ending 2026-06-30: -453,671,000
Quote market capitalization: 1,903,457,161
Total debt · period ending 2026-06-30: 31,171,000
Cash · period ending 2026-06-30: 99,647,000

FMP input reference: 6f641a2bf51a69a6e8cdb13afe7e76557325a462d28890c99da58f5868e3b8e6

EV/EBITDA|Earnings Yield|OCF Yield|FCF Yield|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

AGIO EBITDA Yield Metrics

EBITDA YIELD

N/A

AGIO Competitors' EBITDA Yield

AGIO

Agios Pharmaceuticals, Inc.

Current

Market Cap

$1.90B

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BLFS

BioLife Solutions, Inc.

vs AGIO

Market Cap

$1.89B

EBITDA Yield

0.59%

TTM Avg

0.62%

3Y Avg

0.49%

5Y Avg

0.49%

NVAX

Novavax, Inc.

vs AGIO

Market Cap

$1.88B

EBITDA Yield

N/A

TTM Avg

31.25%

3Y Avg

31.25%

5Y Avg

31.25%

AZTA

Azenta, Inc.

vs AGIO

Market Cap

$1.87B

EBITDA Yield

1.97%

TTM Avg

4.45%

3Y Avg

3.20%

5Y Avg

2.40%

ESTA

Establishment Labs Holdings Inc.

vs AGIO

Market Cap

$1.95B

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

AXGN

AxoGen, Inc.

vs AGIO

Market Cap

$1.96B

EBITDA Yield

N/A

TTM Avg

0.87%

3Y Avg

0.82%

5Y Avg

0.82%

ABSI

Absci Corporation

vs AGIO

Market Cap

$1.84B

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

IMNM

Immunome, Inc.

vs AGIO

Market Cap

$1.97B

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ASTH

Astrana Health, Inc.

vs AGIO

Market Cap

$1.84B

EBITDA Yield

7.40%

TTM Avg

5.95%

3Y Avg

6.07%

5Y Avg

6.49%

NVCR

Novocure Ltd

vs AGIO

Market Cap

$1.83B

EBITDA Yield

N/A

TTM Avg

0.15%

3Y Avg

0.15%

5Y Avg

0.15%

NAME	MARKET CAP	EBITDA YIELD	TTM	3Y	5Y
Agios Pharmaceuticals, Inc. (AGIO)	$1.90B	N/A	N/A	N/A	N/A
BioLife Solutions, Inc. (BLFS)vs ›	$1.89B	0.59%	0.62%	0.49%	0.49%
Novavax, Inc. (NVAX)vs ›	$1.88B	N/A	31.25%	31.25%	31.25%
Azenta, Inc. (AZTA)vs ›	$1.87B	1.97%	4.45%	3.20%	2.40%
Establishment Labs Holdings Inc. (ESTA)vs ›	$1.95B	N/A	N/A	N/A	N/A
AxoGen, Inc. (AXGN)vs ›	$1.96B	N/A	0.87%	0.82%	0.82%
Absci Corporation (ABSI)vs ›	$1.84B	N/A	N/A	N/A	N/A
Immunome, Inc. (IMNM)vs ›	$1.97B	N/A	N/A	N/A	N/A
Astrana Health, Inc. (ASTH)vs ›	$1.84B	7.40%	5.95%	6.07%	6.49%
Novocure Ltd (NVCR)vs ›	$1.83B	N/A	0.15%	0.15%	0.15%

EBITDA Yield Formula & Definition

EBITDA Yield = TTM EBITDA / Enterprise Value

EBITDA yield is the inverse of EV/EBITDA, expressing trailing pre-interest, pre-tax operating cash generation as a percentage of enterprise value. Comparable across leverage levels; higher is cheaper. Not meaningful for banks and insurers.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute